• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLQP 肽在肌萎缩侧索硬化症中的作用:具有神经保护作用的潜在血液生物标志物。

TLQP Peptides in Amyotrophic Lateral Sclerosis: Possible Blood Biomarkers with a Neuroprotective Role.

机构信息

Dept. Biomedical Sciences, University of Cagliari, Monserrato, Italy.

Dept. Biomedical Sciences, University of Cagliari, Monserrato, Italy.

出版信息

Neuroscience. 2018 Jun 1;380:152-163. doi: 10.1016/j.neuroscience.2018.03.023. Epub 2018 Mar 26.

DOI:10.1016/j.neuroscience.2018.03.023
PMID:29588252
Abstract

While the VGF-derived TLQP peptides have been shown to prevent neuronal apoptosis, and to act on synaptic strengthening, their involvement in Amyotrophic Lateral Sclerosis (ALS) remains unclarified. We studied human ALS patients' plasma (taken at early to late disease stages) and primary fibroblast cultures (patients vs controls), in parallel with SOD1-G93A transgenic mice (taken at pre-, early- and late symptomatic stages) and the mouse motor neuron cell line (NSC-34) treated with Sodium Arsenite (SA) to induce oxidative stress. TLQP peptides were measured by enzyme-linked immunosorbent assay, in parallel with gel chromatography characterization, while their localization was studied by immunohistochemistry. In controls, TLQP peptides, including forms compatible with TLQP-21 and 62, were revealed in plasma and spinal cord motor neurons, as well as in fibroblasts and NSC-34 cells. TLQP peptides were reduced in ALS patients' plasma starting in the early disease stage (14% of controls) and remaining so at the late stage (16% of controls). In mice, a comparable pattern of reduction was shown (vs wild type), in both plasma and spinal cord already in the pre-symptomatic phase (about 26% and 70%, respectively). Similarly, the levels of TLQP peptides were reduced in ALS fibroblasts (31% of controls) and in the NSC-34 treated with Sodium Arsenite (53% of decrease), however, the exogeneous TLQP-21 improved cell viability (SA-treated cells with TLQP-21, vs SA-treated cells only: about 83% vs. 75%). Hence, TLQP peptides, reduced upon oxidative stress, are suggested as blood biomarkers, while TLQP-21 exerts a neuroprotective activity.

摘要

虽然 VGF 衍生的 TLQP 肽已被证明可防止神经元凋亡,并作用于突触强化,但它们在肌萎缩侧索硬化症(ALS)中的作用仍不清楚。我们研究了人类 ALS 患者的血浆(取自疾病早期至晚期)和原代成纤维细胞培养物(患者与对照组),同时研究了 SOD1-G93A 转基因小鼠(取自前、早和晚症状阶段)和用亚砷酸钠(SA)处理的小鼠运动神经元细胞系(NSC-34)以诱导氧化应激。通过酶联免疫吸附测定法测量 TLQP 肽,同时进行凝胶色谱分析,同时通过免疫组织化学研究其定位。在对照组中,TLQP 肽,包括与 TLQP-21 和 62 兼容的形式,在血浆和脊髓运动神经元中以及成纤维细胞和 NSC-34 细胞中均被揭示。从疾病早期阶段(对照组的 14%)开始,ALS 患者的血浆中 TLQP 肽减少,并在晚期阶段(对照组的 16%)保持不变。在小鼠中,已显示出类似的减少模式(与野生型相比),在血浆和脊髓中均在无症状前阶段(分别约为 26%和 70%)。同样,ALS 成纤维细胞(对照组的 31%)和用亚砷酸钠处理的 NSC-34 中的 TLQP 肽水平降低(减少约 53%),但是外源性 TLQP-21 可提高细胞活力(用 TLQP-21 处理的 SA 处理的细胞,与仅用 SA 处理的细胞相比:约 83%比 75%)。因此,提示氧化应激时减少的 TLQP 肽作为血液生物标志物,而 TLQP-21 发挥神经保护作用。

相似文献

1
TLQP Peptides in Amyotrophic Lateral Sclerosis: Possible Blood Biomarkers with a Neuroprotective Role.TLQP 肽在肌萎缩侧索硬化症中的作用:具有神经保护作用的潜在血液生物标志物。
Neuroscience. 2018 Jun 1;380:152-163. doi: 10.1016/j.neuroscience.2018.03.023. Epub 2018 Mar 26.
2
VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies.肌萎缩侧索硬化症中的VGF蛋白及其C末端衍生肽:人类和动物模型研究
PLoS One. 2016 Oct 13;11(10):e0164689. doi: 10.1371/journal.pone.0164689. eCollection 2016.
3
Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis.神经肽 VGF 衍生肽 LQEQ-19 在肌萎缩侧索硬化症的体外模型中具有神经保护作用。
Neurochem Res. 2019 Apr;44(4):897-904. doi: 10.1007/s11064-019-02725-4. Epub 2019 Jan 17.
4
Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.Toll样受体4抑制剂TAK-242减轻肌萎缩侧索硬化小鼠模型中的运动功能障碍和脊髓病理变化。
Int J Mol Sci. 2017 Aug 1;18(8):1666. doi: 10.3390/ijms18081666.
5
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.Sigma-1 受体激动剂 PRE-084 在非 SOD1 突变相关运动神经元疾病小鼠模型中的神经保护作用。
Neurobiol Dis. 2014 Feb;62:218-32. doi: 10.1016/j.nbd.2013.10.010. Epub 2013 Oct 16.
6
Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.神经调节蛋白 1 通过恢复脊髓运动神经元的 C-末梢,赋予 SOD1 相关性肌萎缩侧索硬化症小鼠神经保护作用。
Acta Neuropathol Commun. 2016 Feb 18;4:15. doi: 10.1186/s40478-016-0286-7.
7
VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese Mice.2型糖尿病患者血浆和肥胖小鼠中的VGF肽谱
PLoS One. 2015 Nov 12;10(11):e0142333. doi: 10.1371/journal.pone.0142333. eCollection 2015.
8
Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.胍那苄可延缓疾病症状的出现,延长寿命,改善运动能力,并减轻肌萎缩侧索硬化症SOD1 G93A小鼠模型中的运动神经元损失。
Neuroscience. 2014 Sep 26;277:132-8. doi: 10.1016/j.neuroscience.2014.03.047. Epub 2014 Mar 31.
9
Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.5-甲基四氢叶酸水平降低:一种潜在的肌萎缩侧索硬化症症状前生物标志物。
J Neurol Sci. 2010 Jun 15;293(1-2):102-5. doi: 10.1016/j.jns.2010.02.024. Epub 2010 Mar 23.
10
Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.JGK-263对肌萎缩侧索硬化转基因SOD1-G93A小鼠的神经保护作用。
J Neurol Sci. 2014 May 15;340(1-2):112-6. doi: 10.1016/j.jns.2014.03.008. Epub 2014 Mar 12.

引用本文的文献

1
VGF and Its Derived Peptides in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的VGF及其衍生肽
Brain Sci. 2025 Mar 22;15(4):329. doi: 10.3390/brainsci15040329.
2
Brain-Biomarker Changes in Body Fluids of Patients with Parkinson's Disease.帕金森病患者体液中的脑-生物标志物变化。
Int J Mol Sci. 2023 Jun 30;24(13):10932. doi: 10.3390/ijms241310932.
3
Associations of VGF with Neuropathologies and Cognitive Health in Older Adults.老年人群中 VGF 与神经病理学和认知健康的关联。
Ann Neurol. 2023 Aug;94(2):232-244. doi: 10.1002/ana.26676. Epub 2023 May 25.
4
TLQP-21 is a low potency partial C3aR activator on human primary macrophages.TLQP-21 是一种低效力的人类原代巨噬细胞 C3aR 部分激动剂。
Front Immunol. 2023 Jan 26;14:1086673. doi: 10.3389/fimmu.2023.1086673. eCollection 2023.
5
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases.VGF作为神经退行性疾病和精神疾病的生物标志物及治疗靶点。
Brain Commun. 2021 Oct 27;3(4):fcab261. doi: 10.1093/braincomms/fcab261. eCollection 2021.
6
Identification of VGF nerve growth factor inducible-producing cells in human spinal cords and expression change in patients with amyotrophic lateral sclerosis.鉴定人脊髓中 VGF 神经生长因子诱导产生细胞及肌萎缩性侧索硬化症患者的表达变化。
Int J Med Sci. 2020 Feb 4;17(4):480-489. doi: 10.7150/ijms.39101. eCollection 2020.
7
TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.TLQP-21,一种具有内分泌和外分泌特性的 VGF 衍生肽:关注体外钙信号。
Int J Mol Sci. 2019 Dec 24;21(1):130. doi: 10.3390/ijms21010130.
8
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies.路易体痴呆患者脑脊液中的 VGF 肽。
Int J Mol Sci. 2019 Sep 20;20(19):4674. doi: 10.3390/ijms20194674.
9
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS.肌萎缩侧索硬化症中建议的分子分层、生物标志物及其组织来源的系统评价
Front Neurol. 2019 May 14;10:400. doi: 10.3389/fneur.2019.00400. eCollection 2019.